RxDoctor Payments Data

Sarath Nath

Infectious Disease · Brooklyn, NYNPI 1265852446

Payments from drug & device makers

$3,203in general payments, 2019–2025

Across 12 payments — averaging $266.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$3K
  • Astellas Pharma US Inc$123
  • Shionogi Inc$21
  • AstraZeneca$20
  • AbbVie$19
  • Gilead$16

What the payments were for

  • Consulting fees$2,76086%
  • Food & beverage$38812%
  • Education$552%

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,203 in reported general payments places this provider in the 75th percentile of 799 infectious disease providers in New York.

See all infectious disease providers in New York

Medicare billing

Part B allowed, 2024
$135,443
Medicare patients
443
Services billed
886

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CeftriaxoneCeftriaxone Sodium28$4,878
Piperacillin-TazobactamPiperacillin Sodium/Tazobactam14$3,430
Doxycycline Hyclate19$730
Rifampin14$489
Minocycline Hcl13$292
Cefadroxil12$98
CefuroximeCefuroxime Axetil14$41

Paid to pharmacies, not to this prescriber.

Other infectious disease in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →